Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Renert-Yuval

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|April 19, 2025
Chronic hand eczema treatment: exploring topical JAK inhibition furtherYael Renert-Yuval
The Lancet. Child & Adolescent Health|June 3, 2026
Navigating the complexity of adolescent chronic hand eczemaYael Renert-Yuval
Allergy|June 30, 2022
Reply to: "Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients"Yael Renert-Yuval, Emma Guttman-Yassky
Dermatologic Clinics|March 10, 2019
What's New in Atopic DermatitisYael Renert-Yuval, Emma Guttman-Yassky
Current Opinion in Allergy and Clinical Immunology|June 6, 2018
Monoclonal antibodies for the treatment of atopic dermatitisYael Renert-Yuval, Emma Guttman-Yassky
Expert Opinion on Biological Therapy|May 11, 2016
A novel therapeutic paradigm for patients with extensive alopecia areataYael Renert-Yuval, Emma Guttman-Yassky
Advances in Therapy|June 25, 2017
The Changing Landscape of Alopecia Areata: The Therapeutic ParadigmYael Renert-Yuval, Emma Guttman-Yassky
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2019
New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokinesYael Renert-Yuval, Emma Guttman-Yassky
Lancet (London, England)|July 21, 2024
Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczemaYael Renert-Yuval, Emma Guttman-Yassky
Clinics in Dermatology|July 16, 2017
Systemic therapies in atopic dermatitis: The pipelineYael Renert-Yuval, Emma Guttman-Yassky
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|April 19, 2025
Chronic hand eczema treatment: exploring topical JAK inhibition furtherYael Renert-Yuval
The Lancet. Child & Adolescent Health|June 3, 2026
Navigating the complexity of adolescent chronic hand eczemaYael Renert-Yuval
Allergy|June 30, 2022
Reply to: "Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients"Yael Renert-Yuval, Emma Guttman-Yassky
Dermatologic Clinics|March 10, 2019
What's New in Atopic DermatitisYael Renert-Yuval, Emma Guttman-Yassky
Current Opinion in Allergy and Clinical Immunology|June 6, 2018
Monoclonal antibodies for the treatment of atopic dermatitisYael Renert-Yuval, Emma Guttman-Yassky
Expert Opinion on Biological Therapy|May 11, 2016
A novel therapeutic paradigm for patients with extensive alopecia areataYael Renert-Yuval, Emma Guttman-Yassky
Advances in Therapy|June 25, 2017
The Changing Landscape of Alopecia Areata: The Therapeutic ParadigmYael Renert-Yuval, Emma Guttman-Yassky
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2019
New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokinesYael Renert-Yuval, Emma Guttman-Yassky
Lancet (London, England)|July 21, 2024
Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczemaYael Renert-Yuval, Emma Guttman-Yassky
Clinics in Dermatology|July 16, 2017
Systemic therapies in atopic dermatitis: The pipelineYael Renert-Yuval, Emma Guttman-Yassky
Pageof 7